Ecosystem
Diverse, Growing, Strategic
Our innovations and efforts are driving validation and proprietary value at every stage of drug discovery for the world’s largest pharmaceutical and clinical brands. BioSymetrics is also building a growing ecosystem of experimental partners and platforms to validate predictions across model systems.
Interested in Partnering?
We seek partners with a desire to transform drug discovery, to help advance our drug discovery programs or embark on new programs in cardiac, neurodegenerative and rare diseases.
We are highly collaborative experts in machine learning, data science and drug discovery. Let’s chat.